pepmg_

Study summary · research use only

Teriparatide-induced atrial tachycardia

Observational · human · BMJ case reports · 2018 · DOI 10.1136/bcr-2017-223035 · PMID 29487102

Plain-language summary

Paraphrased from the published abstract below — not a verdict on whether anything works.

This is a case report describing a human patient who presented with worsening chest pain and tachycardia, monitored remotely via her pacemaker. The patient had started the injectable medication teriparatide (Forteo), after which her symptoms increased. She was found to have intermittent atrial tachycardia with 1:1 conduction and occasional atrioventricular block transiently, coinciding with her teriparatide injection. The authors state this specific-associated arrhythmia had not previously been described.

Abstract

We present the case of a patient who presented with worsening chest pain and tachycardia. We were able to monitor her remotely through her pacemaker. She had been started on the injectable medication teriparatide (Forteo) and since then she had an increase in her symptoms. She was found to have intermittent atrial tachycardia with 1:1 conduction and occasional atrioventricular block transiently, coinciding with her injection of teriparatide. This specific-associated arrhythmia has yet to be described.

Read the full study on PubMed ↗ Open-access full text ↗

pepmg summarizes the peer-reviewed literature and links to every source — it sells nothing, ships nothing, and gives no medical, dosing, or human-use guidance. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.